BioCentury | Mar 26, 2021
Finance

March 25 Quick Takes: Lava flows down on first day after $100.5M IPO; plus Scipher, Eliem, Brii, Bioheng, RiverVest, JSR Life Science and Apnimed

...Decheng Capital; and Ting Jia’s Octagon Capital, with the participation by BlueRun Ventures China and Shenzhen Capital Group...
BioCentury | May 14, 2020
Finance

May 13 Quick Takes: MyoKardia raises $551M; plus Legend looks to NASDAQ for IPO and ADC, Travecta, QureBio, Kintor, Lantern, Kiromic

...financing QureBio Ltd. said it has raised tens of millions in an A+ round from Shenzhen Capital Group...
BioCentury | Mar 9, 2020
Finance

GenFleet eyes proof of concept with $50M series B

...GenFleet raised more than $50 million in a series B round led by CDH and Shenzhen Capital group...
BioCentury | Jan 3, 2020
Financial News

Jan. 3 Financial Quick Takes: Black Diamond plots IPO; plus Oxford Nanopore, CF PharmTech, Mygene and Zerun

...Diagnostics Co. Ltd. raised RMB100 million ($14.3 million) in a series B round co-led by Shenzhen Capital Group...
BioCentury | Jan 19, 2018
Financial News

China's Kintor, Zelgen complete financings

...million ($62.1 million) on Jan. 15 in a series B round led by Mingsheng Insurance, Shenzhen Capital Group...
BioCentury | Jan 16, 2018
Financial News

China's Kintor, Zelgen complete financings

...RMB400 million ($62.1 million) on Monday in a series B round led by Mingsheng Insurance, Shenzhen Capital Group...
BioCentury | Jan 6, 2017
Financial News

Frontier Biotechnologies completes venture financing

...RMB300 million ($43.2 million) in a series C round led by Huaxin Century Investment Group. Shenzhen Capital Group...
Items per page:
1 - 7 of 7
BioCentury | Mar 26, 2021
Finance

March 25 Quick Takes: Lava flows down on first day after $100.5M IPO; plus Scipher, Eliem, Brii, Bioheng, RiverVest, JSR Life Science and Apnimed

...Decheng Capital; and Ting Jia’s Octagon Capital, with the participation by BlueRun Ventures China and Shenzhen Capital Group...
BioCentury | May 14, 2020
Finance

May 13 Quick Takes: MyoKardia raises $551M; plus Legend looks to NASDAQ for IPO and ADC, Travecta, QureBio, Kintor, Lantern, Kiromic

...financing QureBio Ltd. said it has raised tens of millions in an A+ round from Shenzhen Capital Group...
BioCentury | Mar 9, 2020
Finance

GenFleet eyes proof of concept with $50M series B

...GenFleet raised more than $50 million in a series B round led by CDH and Shenzhen Capital group...
BioCentury | Jan 3, 2020
Financial News

Jan. 3 Financial Quick Takes: Black Diamond plots IPO; plus Oxford Nanopore, CF PharmTech, Mygene and Zerun

...Diagnostics Co. Ltd. raised RMB100 million ($14.3 million) in a series B round co-led by Shenzhen Capital Group...
BioCentury | Jan 19, 2018
Financial News

China's Kintor, Zelgen complete financings

...million ($62.1 million) on Jan. 15 in a series B round led by Mingsheng Insurance, Shenzhen Capital Group...
BioCentury | Jan 16, 2018
Financial News

China's Kintor, Zelgen complete financings

...RMB400 million ($62.1 million) on Monday in a series B round led by Mingsheng Insurance, Shenzhen Capital Group...
BioCentury | Jan 6, 2017
Financial News

Frontier Biotechnologies completes venture financing

...RMB300 million ($43.2 million) in a series C round led by Huaxin Century Investment Group. Shenzhen Capital Group...
Items per page:
1 - 7 of 7